TickerLeague

EBITDA for Centene (CNC)

According to Centene's latest reported financial statements, the company's current EBITDA (TTM) is -$5.11B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

-$5.11B

YoY change

-182.9%

5Y CAGR

N/A

Peak year (2024)

$6.20B

Cumulative EBITDA

$31.06B

EBITDA history chart for Centene (CNC) from 1999 to 2025

EBITDA history table for Centene (CNC) from 1999 to 2025

Fiscal yearPeriod endedReportedEBITDAYoY
2025-$5.14B-182.9%
2024$6.20B+10.4%
2023$5.62B+38.4%
2022$4.06B+6.4%
2021$3.81B-19.9%
2020$4.76B+67.8%
2019$2.84B+28.6%
2018$2.21B+26.1%
2017$1.75B+5.7%
2016$1.66B+94.5%
2015$851.00M+46.5%
2014$581.00M+60.1%
2013$363.00M+73.7%
2012$209.00M-21.7%
2011$267.00M+19.0%
2010$224.27M+13.4%
2009$197.83M+4.8%
2008$188.70M+75.5%
2007$107.50M+1021.7%
2006$9.58M-90.7%
2005$102.92M+27.1%
2004$80.98M+38.3%
2003$58.53M+33.8%
2002$43.75M+115.3%
2001$20.32M+169.0%
2000$7.55M-214.2%
1999-$6.61M

EBITDA values are taken from Centene's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

The 2025 reading of Centene (CNC) EBITDA is -$5.14B – plunged 182.9% year-over-year.

Centene EBITDA plunged from $6.20B in 2024 to -$5.14B in 2025, a 182.9% drawdown.

The highest annual EBITDA of $6.20B was reported in 2024. The lowest in the available history was -$5.14B in 2025.

Within Healthcare, Centene (CNC) ranks 9th among 8 peers we track. The peer median for EBITDA is $24.21B.

Centene EBITDA by Year

Centene EBITDA 2025: -$5.14B

Centene EBITDA in 2025 was -$5.14B, plunged 182.9% below 2024. This figure represents the lowest annual value in the available history.

Centene EBITDA 2024: $6.20B

Centene EBITDA in 2024 was $6.20B, grew 10.4% from 2023. This figure represents the highest annual value in the available history.

Centene EBITDA 2023: $5.62B

Centene EBITDA in 2023 was $5.62B, surged 38.4% from 2022.

Centene EBITDA 2022: $4.06B

Centene EBITDA in 2022 was $4.06B, grew 6.4% from 2021.

Centene EBITDA 2021: $3.81B

Centene EBITDA in 2021 was $3.81B.

See more financial history for Centene (CNC).

Sector peers — EBITDA

Companies in the same sector as Centene, ranked by their latest EBITDA.

CompanyEBITDASector
Novo Nordisk A/S (NVO)$156.73BHealthcare
Johnson & Johnson (JNJ)$41.05BHealthcare
Eli Lilly and Company (LLY)$27.94BHealthcare
Merck & Co., Inc. (MRK)$25.36BHealthcare
UnitedHealth Group Incorporated (UNH)$23.06BHealthcare
AstraZeneca PLC (AZN)$19.83BHealthcare
AbbVie Inc. (ABBV)$17.63BHealthcare
Amgen Inc. (AMGN)$15.84BHealthcare

Frequently asked questions

What is Centene's EBITDA?

Latest reported EBITDA for Centene (CNC) is -$5.11B (period ending March 31, 2026).

How has Centene EBITDA changed year-over-year?

Centene (CNC) EBITDA changed -182.9% year-over-year on the latest annual filing.

When did Centene EBITDA hit its highest annual value?

Centene EBITDA reached its highest annual value of $6.20B in 2024.

What was Centene EBITDA in 2024?

Centene (CNC) EBITDA in 2024 was $6.20B.

What was Centene EBITDA in 2025?

Centene (CNC) EBITDA in 2025 was -$5.14B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.